Michael A. Chirigos - Concepedia

Author

Michael A. Chirigos

National Cancer Institute

Also Known As

M A CHIRIGOS, M A Chirigos, M Chirigos, MICHAEL A. CHIRIGOS, Michael A. Chirigos, Michael Chirigos, MichaelA. Chirigos

126

Publications

3.5K

Citations

H-Index

119

Concepts

All Affiliations

National Cancer Institute National Institutes of Health Frederick National Laboratory for Cancer Research United States Army Medical Research Institute of Infectious Diseases

About

Michael A. Chirigos is an author at National Cancer Institute specializing in medicine, immunology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	58	2.6K
2	Health Sciences	5	5	97
3	Natural Sciences	2	2	90
4	Engineering	1	1	37
5	Public Health	1	1	15

Michael A. Chirigos

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Interferon: An Inducer of Macrophage Activation by Polyanions Richard M. Schultz, Joseph Papamatheakis, Michael A. Chirigos Science InflammationMacrophage BiologyResting MacrophagesMacrophage IfCytokine	1977	273
Pyran copolymer as an effective adjuvant to chemotherapy against a murine leukemia and solid tumor. Stephen J. Mohr, Michael A. Chirigos, Frederick S. Fuhrman, PubMed Nsc 46015Chemoprevention StrategyImmunologySolid TumorPharmacotherapy	1975	272
Regulation of Macrophage Tumoricidal Function: A Role for Prostaglandins of the E Series Richard M. Schultz, Nicholas Pavlidis, William A. Stylos, Science Chemoprevention StrategyImmunologyPathologyCell DeathImmunologic Mechanism	1978	215
Uptake of Tyrosine by Rat Brain in Vivo Michael A. Chirigos, Paul Greengard, Sidney Udenfriend Journal of Biological Chemistry NeurophysiologyNeuroanatomyMedicineNeuroscienceNervous System	1960	182
Functional and morphologic characteristics of interferon-treated macrophages Richard M. Schultz, Michael A. Chirigos, Ursula Heine Cellular Immunology InflammationMacrophage BiologyCytokineInterferon-treated MacrophagesImmunology	1978	88
Similarities among factors that render macrophages tumoricidal in lymphokine and interferon preparations. Richard M. Schultz, Michael A. Chirigos PubMed ImmunologyPathologyImmunologic MechanismImmunotherapeuticsImmune System	1978	76
Augmenting agents in cancer therapy Evan M. Hersh, Michael A. Chirigos, Michael J. Mastrangelo Cancer TherapyMedicinePharmacologyCombined Modality TreatmentAnti-cancer Agent	1981	74
A simple micro method for the direct determination of δ-amino[14Clevulinic acid production in murine spleen and liver homogenates Paul S. Ebert, Donald P. Tschudy, Jawahar N. Choudhry, Biochimica et Biophysica Acta (BBA) - General Subjects BiochemistryLiver PhysiologyBioanalysisSimple Micro MethodChromatography	1970	69
A TIBO derivative, R82913, is a potent inhibitor of HIV-1 reverse transcriptase with heteropolymer templates E. Lucile White, Robert W. Buckheit, Larry J. Ross, Antiviral Research Medicinal ChemistryAntiviral CompoundMedicineNatural SciencesHuman Retrovirus	1991	67
Association of macrophage activation with antitumor activity by synthetic and biological agents. Richard M. Schultz, Joseph Papamatheakis, Josef Luetzeler, PubMed Antitumor ActivityPyran-activated MacrophagesChemoprevention StrategyMacrophage ActivationImmunology	1977	63

Page 1